Medisafe has a massive database on patients behavior. This product represents one slice of this data. We can create tailored surveys that allow you to have a direct communication channel with patients. If you have a custom specific request - contact us at dataaws@medisafe.com)

More Information

• All questions and requests should be directed to : dataaws@medisafe.com
• More information at https://www.medisafe.com/ 
• Learn what you can do with our data here: https://www.medisafe.com/mediscoveries/medisafe-discovers-mismanagement-of-leading-  asthma-medication/
• To see how this product is structured and what it contains - please download our free product "Free Data Samples (https://us-east-  1.console.aws.amazon.com/junto/home?region=us-east-1#/products/prodview- bytbvuy4fbkhw)” on the marketplace. General description of offered products:

Medisafe is a global leader in digital medication management with over five million users for the past six years, our platform has collected 12 billion data points of medication behavior across all existing therapeutic areas. Our medication management data drills down to a very granular level to identify medication behaviors. We collect demographic characteristics reported from our users as well as objective data from their self-reported medication management behavior and engagement interactions through our app. This data is completely dependent on user engagement based off of self- reported activities. Medisafe has conducted multiple studies with IQVIA to validate self- reported activities with Rx fills. Our massive medication behavior database can be sliced by many different dimensions to conduct high-level, macro medication analysis to drilling down to specific behavior driven activity and perceptions by brands. The data products on the AWS platform are first sliced by drug class and time frame on a macro level covering users on brands, adherence and other medications. The next levels of our data products reveal unique real-world insights into adherence and behavioral activities by users on brands in drug classes. The final level of our data set provides user perceptions into the identified behaviors and activities in the previous data products. Each data set includes de-identified user demographic information in US and relevant data points by the drug class covering a three-month period of the latest quarter in the current year. While the data products can be purchased exclusively, they can also be combined with linking unique user identifications to provide granular insight into behavior patterns. Medisafe is HIPAA compliant applying de-identified user IDs. The data products uploaded in the AWS market place represents the most requested data insights. We invite you to submit your request here dataaws@medisafe.com and we will reach out to discuss terms and prices. In general, the pricing of each data product depends on the size of the drug class, the time period of the data and the additional geographic locations requested. Subscription to the products offered on this platform is renewed annually and provides access to a single data file which is a snapshot of all the actual real-world data in the Medisafe database collected in the latest quarter of the year. To expand the historical datasets please contact us at dataaws@medisafe.com